3-/3,5-Styryl-Substituted BODIPY with N-Bridged Annulation: Synthesis and Spectroscopic Properties
Synthesis · 2024-06 · 56 (11) · 1735-1740
DOI: 10.1055/a-2226-4082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, online erschienen am 19.01.2024. Verfasst von Lizhi Gai und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Education of Zhejiang Province.
Abstract (Originalsprache)
The development of organic dyes with high fluorescence quantum yield (FLQY) and tunable emission has significant application potential in biomedicine and material science. The synthesis of four N-bridged annulated BODIPY dyes with styryl units at the 3- and 3,5-positions of the BODIPY core, introduced by Knoevenagel condensation reaction, is reported. These dyes show high FLQY and tunable fluorescence. The intrinsic relationship between structure and properties is comprehensively analyzed through density functional theory (DFT) calculations, which is crucial for the rational design of new BODIPY dyes with desired properties for specific applications.
Förderung
- National Natural Science Foundation of China
- Department of Education of Zhejiang Province
Zitieren
APA
Gai, L., Chang, L., Zhou, S., Kong, X., & Lu, H. (2024). 3-/3,5-Styryl-Substituted BODIPY with N-Bridged Annulation: Synthesis and Spectroscopic Properties. Synthesis, 56(11), 1735-1740. https://doi.org/10.1055/a-2226-4082
Vancouver
Gai L, Chang L, Zhou S, Kong X, Lu H. 3-/3,5-Styryl-Substituted BODIPY with N-Bridged Annulation: Synthesis and Spectroscopic Properties. Synthesis. 2024;56(11):1735-1740. doi:10.1055/a-2226-4082
BibTeX
@article{Gai2024,
author = {Gai, Lizhi and Chang, Le and Zhou, Shengjie and Kong, Xiangduo and Lu, Hua},
title = {3-/3,5-Styryl-Substituted BODIPY with N-Bridged Annulation: Synthesis and Spectroscopic Properties},
journal = {Synthesis},
year = {2024},
volume = {56},
number = {11},
pages = {1735--1740},
doi = {10.1055/a-2226-4082}
}
EUVIMED